T0	VerySpecificPopulation 23185 23261	the relatively low plasma concentrations of TNF-α in this cohort of patients
T1	Population 23949 24056	confounding factors such as those related to pharmacokinetic and pharmacodynamic variation between subjects
T2	NonstandardTreatmentCharacteristics 24061 24102	the effects of concurrent medical therapy
T3	Intervention 24330 24441	more rapid treatment (within the first 24 h) and higher doses of etanercept may have produced different results
